Pharma giants open up drug patents in new collaboration

October 26, 2011 in Medications

Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.

The cooperation is aimed at the development of and vaccines for around 20 diseases, including neglected tropical diseases, malaria and tuberculosis, and will involve major drugmakers including Novartis, AstraZeneca, GlaxoSmithKline, Pfizer, Merck and Sanofi.

AstraZeneca chief executive David Brennan said the British would make all its patents available to the collaboration called WIPO Re:Search.

"WIPO Re:Search has the potential to make a real impact on , which is why we are proud to make all patents owned by AstraZeneca available to this important initiative," he said.

Under the scheme, the intellectual property licences on these drugs would be available free of charge for the world's poorest countries, said Francis Gurry, who heads the Agency.

Developed nations meanwhile would have to negotiate for the licences, although Gurry said the fee levied would be "modest."

Some are regarded to be "neglected," as just one percent of the 1,400 drugs developed between 1975 and 1999 were targetted at illnesses which affect one in every six persons, according to the .

These diseases threaten the lives of a billion people in the world, the health agency added.

Medecins sans Frontieres however, criticised the WIPO initiative, noting that it offers royalty-free licences to least developed countries only.

It noted that many people affected by the diseases are not in the least developed countries. These countries would have to negotiate for access to patents on a case-by-case basis.

"WIPO is taking an unacceptable step in the wrong direction by setting the bar for access too low," said the medical NGO.

(c) 2011 AFP

5 /5 (1 vote)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Sean_W
Oct 26, 2011

Rank: not rated yet
"Medecins sans Frontieres however, criticised the WIPO initiative, noting that it offers royalty-free licences to least developed countries only.
"


That's like criticizing a company like a Wal-Mart for donating to a local food bank that only serves the poor just because some rich people have malnourished kids who won't benefit. Drug companies are not founded to give free drugs to everyone. Well, some might be but unsurprisingly they don't stay in business very long. These companies make a massively charitable act and all some people can say is: why don't you do more? Why don't you give everything and go out of business?

No good deed goes unpunished.
hush1
Oct 26, 2011

Rank: not rated yet
No 'social' medical care. Be consequential. Be consistent.
Rank 5 /5 (1 vote)
Related Stories
Relevant PhysicsForums posts

More news stories

Acne pill benefits outweigh blood clot risk: EU agency

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins—when correctly prescribed.

Medications created May 17, 2013 | popularity not rated yet | comments 0

First influenza vaccine brought to clinical testing

Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...

Medications created May 17, 2013 | popularity not rated yet | comments 0

Aspirin not always best treatment for many individuals

(Medical Xpress)—An aspirin a day may not always keep heart disease away, say two University of Florida cardiologists. But a new algorithm they have developed outlines factors physicians should weigh as ...

Medications created May 16, 2013 | popularity 3.5 / 5 (2) | comments 0 | with audio podcast

FDA: lower ambien's dose to prevent drowsy driving

(HealthDay)—The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien (zolpidem) in an effort to cut down on daytime drowsiness that could be a hazard ...

Medications created May 15, 2013 | popularity not rated yet | comments 0

Simponi approved for ulcerative colitis

(HealthDay)—Simponi (golimumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe ulcerative colitis.

Medications created May 15, 2013 | popularity not rated yet | comments 0


New case of SARS-like virus in Saudi: ministry

A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

New colonoscope provides ground-breaking view of colon

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...